Crawley Clinical Commissioning Group (CCCG) and GlaxoSmithKline UK (GSK) Osteoporosis

Joint Working Summary

Crawley

Crawley Clinical Commissioning Group (CCCG) and GlaxoSmithKline UK Limited (GSK UK Limited) working jointly to evaluate and subsequently improve the efficiency of osteoporosis care from the Fracture Liaison Service (FLS).

Benefits of the project to the patient will be to:

  • Increase quality of care closer to home
  • Improved continuity of care with the FLS
  • High risk patients identified and receive appropriate treatment
  • Better experience of the healthcare system

Start date – Oct 12

Finish date – To be confirmed

For further information contact

GSK UK Limited Customer contact no +44 (0) 800221441

 

UK/COM/0053/13(1) Archived 2015.